TVGN logo

Tevogen Bio Holdings (TVGN) Company Overview

Profile

Full Name:

Tevogen Bio Holdings Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 5, 2022

Indexes:

Not included

Website:

http://tevogen.com

Description:

Tevogen Bio Holdings (TVGN) is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases. They utilize advanced cell therapy techniques to create personalized treatments, aiming to improve patient outcomes and enhance the immune system's ability to fight diseases.

Key Details

Price

$1.06

Market Cap

$185.55 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.00(-101.09% YoY)

PE Ratio

36.43

Annual ROE

9.67%

Annual Debt To Equity

-2.35

Beta

0.71

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 19, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 D. Boral Capital
Buy

Screeners with TVGN included

Growing Shares Outstanding
US stocks
Most recommended stocks
Best performing stocks last 3 months
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies
Earnings this week
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.06
TVGN price is $1.06

Price All-time High

$11.37
TVGN price is currently -90.68% below its historical high of $11.37

Price Analysts Target

$10.00
TVGN price is currently -89.40% lower than the consensus analysts' forecast

Price Today Change

-1.84%
TVGN price is down -1.84% today

Price YTD Change

+1.93%
TVGN price is up +1.93% since January 1st

Price 3-Year Change

-89.34%
TVGN price is down -89.34% over the past 3 years

Market cap

Market Cap

$185.55 M
TVGN market capitalization is $185.55 million

Market Cap 3-Year Change

-
TVGN market capitalization 3-year change is unknown

Market Cap All-time High

$1.79 B
TVGN market capitalization is currently -89.66% below its historical high of $1.79 billion

Market Cap Sector Rank

55.06%
TVGN market capitalization is higher than 55.06% of companies in Healthcare sector

Technical

Beta

0.71
TVGN beta is 0.71

200-day SMA

$1.02
TVGN price is currently +3.87% above its 200-day simple moving average

14-day RSI

36.59
TVGN 14-day relative strength index is 36.59

30-day Relative Volume

0.21
TVGN 30-day relative volume is 0.21

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
TVGN annual revenue value is unknown

Annual Revenue Analysts Estimate

-
TVGN annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
TVGN annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
TVGN annual revenue is unknown

Profit

Annual Gross Profit

-
TVGN annual gross profit value is unknown

Annual Gross Margin

-
TVGN annual gross profit margin value is unknown

Annual Operating Profit

-$2.27 M
TVGN annual operating income is -$2.27 million

Annual Operating Margin

-
TVGN annual operating profit margin value is unknown

Annual Net Income

-$67.30 K
TVGN annual net profit is -$67.30 thousand

Annual Net Margin

-
TVGN annual net profit margin value is unknown

EPS

Annual EPS

-$0.00
TVGN annual earnings per share is -$0.00

Annual EPS Analysts Estimate

-
TVGN annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-101.09%
TVGN annual earnings per share is down -101.09% year-on-year

Annual EPS Sector Rank

82.57%
TVGN annual earnings per share is higher than 82.57% of companies in Healthcare sector

ROA & ROE

Annual ROA

-0.40%
TVGN annual return on assets is -0.40%

Annual ROE

9.67%
TVGN annual return on equity is 9.67%

EBIT & EBITDA

Annual EBIT

$188.70 K
TVGN annual earnings before interest & taxes is $188.70 thousand

Annual EBITDA

$188.70 K
TVGN annual EBITDA is $188.70 thousand

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

36.43
TVGN price to earnings ratio is 36.43

PE Ratio Sector Rank

67.98%
TVGN price to earnings ratio is higher than 67.98% of companies in Healthcare sector

PB Ratio

PB Ratio

-14.28
TVGN price to book ratio is -14.28

PB Ratio Sector Rank

2.22%
TVGN price to book ratio is higher than 2.22% of companies in Healthcare sector

PS Ratio

PS Ratio

-
TVGN price to sales ratio value is unknown

PS Ratio Sector Rank

-
TVGN price to sales ratio is unknown

Enterprise value

Enterprise Value

$186.19 M
TVGN enterprise value is $186.19 million

Enterprise Value Sector Rank

56.43%
TVGN enterprise value is higher than 56.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.49
TVGN EV/EBITDA is 3.49

EV/EBITDA Sector Rank

77.76%
TVGN EV/EBITDA is higher than 77.76% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.12
TVGN annual current ratio is 0.12

Annual Quick Ratio

-
TVGN annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-2.35
TVGN annual debt to equity ratio is -2.35

Annual Interest Coverage Ratio

0.74
TVGN annual interest coverage ratio is 0.74

Risk & Stability

Piotroski F-Score

-
TVGN piotroski f-score value is unknown

Altman Z-Score

-
TVGN altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$17.04 M
TVGN annual total assets is $17.04 million

Annual Non Current Assets

$16.68 M
TVGN annual long term assets is $16.68 million

Annual Current Assets

$355.80 K
TVGN annual total current assets is $355.80 thousand

Annual Cash & Cash Equivalents

$8800.00
TVGN annual cash & cash equivalents is $8800.00

Equity

Annual Book Value

-$695.80 K
TVGN annual book value is -$695.80 thousand

Annual Working Capital

-$2.65 M
TVGN annual working capital is -$2.65 million

Liabilities

Annual Total Liabilities

$17.73 M
TVGN annual total liabilities is $17.73 million

Annual Total Long Term Liabilities

$14.73 M
TVGN annual total long term liabilities is $14.73 million

Annual Current Liabilities

$3.00 M
TVGN annual total current liabilities is $3.00 million

Annual Accounts Payable

$1.14 M
TVGN annual accounts payable is $1.14 million

Debt

Annual Total Debt

$1.63 M
TVGN annual total debt is $1.63 million

Annual Total Debt 1-Year Change

+100%
TVGN annual total debt is up +100% year-on-year

Annual Long Term Debt

-
TVGN annual long term debt value is unknown

Annual Short Term Debt

$1.63 M
TVGN annual short term debt is $1.63 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$2.27 M
TVGN annual total expenses is $2.27 million

Annual Operating Expenses

$2.27 M
TVGN annual total operating expenses is $2.27 million

Annual Cost Of Goods Sold

-
TVGN annual cost of goods sold value is unknown

Annual SGA

$2.27 M
TVGN annual SGA is $2.27 million

Annual D&A

-
TVGN annual depreciation & amortization value is unknown

Annual Interest Expense

$256.00 K
TVGN annual interest expense is $256.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$1.38 M
TVGN annual cash flow from operations is -$1.38 million

Annual CFO 1-Year Change

-539%
TVGN annual cash flow from operations is down -539% year-on-year

Annual CFI

$342.92 M
TVGN annual cash flow from investing activities is $342.92 million

Annual CFI 1-Year Change

+100%
TVGN annual cash flow from investing activities is up +100% year-on-year

Annual CFF

-$341.66 M
TVGN annual cash flow from financing activities is -$341.66 million

Annual CFF 1-Year Change

-100%
TVGN annual cash flow from financing activities is down -100% year-on-year

Free CashFlow

Annual FCF

-$1.38 M
TVGN annual free cash flow is -$1.38 million

Annual FCF 1-Year Change

-539%
TVGN annual free cash flow is down -539% year-on-year

CAPEX

Annual CAPEX

-
TVGN annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
TVGN annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

INBX logo
Inhibrx Biosciences (INBX)
KOD logo
Kodiak Sciences (KOD)
INGN logo
Inogen (INGN)
Contineum Therapeutics Class A (CTNM)
ARAY logo
Accuray Incorporated (ARAY)
NVCT logo
Nuvectis Pharma (NVCT)
HITI logo
High Tide (HITI)
DRTS logo
Alpha Tau Medical (DRTS)
AIRS logo
AirSculpt Technologies (AIRS)

FAQ

  • What is the ticker symbol for Tevogen Bio Holdings?
  • Does Tevogen Bio Holdings pay dividends?
  • What sector is Tevogen Bio Holdings in?
  • What industry is Tevogen Bio Holdings in?
  • What country is Tevogen Bio Holdings based in?
  • When did Tevogen Bio Holdings go public?
  • Is Tevogen Bio Holdings in the S&P 500?
  • Is Tevogen Bio Holdings in the NASDAQ 100?
  • Is Tevogen Bio Holdings in the Dow Jones?
  • When was Tevogen Bio Holdings's last earnings report?
  • When does Tevogen Bio Holdings report earnings?
  • Should I buy Tevogen Bio Holdings stock now?

What is the ticker symbol for Tevogen Bio Holdings?

The ticker symbol for Tevogen Bio Holdings is NASDAQ:TVGN

Does Tevogen Bio Holdings pay dividends?

No, Tevogen Bio Holdings does not pay dividends

What sector is Tevogen Bio Holdings in?

Tevogen Bio Holdings is in the Healthcare sector

What industry is Tevogen Bio Holdings in?

Tevogen Bio Holdings is in the Biotechnology industry

What country is Tevogen Bio Holdings based in?

Tevogen Bio Holdings is headquartered in United States

When did Tevogen Bio Holdings go public?

Tevogen Bio Holdings's initial public offering (IPO) was on January 5, 2022

Is Tevogen Bio Holdings in the S&P 500?

No, Tevogen Bio Holdings is not included in the S&P 500 index

Is Tevogen Bio Holdings in the NASDAQ 100?

No, Tevogen Bio Holdings is not included in the NASDAQ 100 index

Is Tevogen Bio Holdings in the Dow Jones?

No, Tevogen Bio Holdings is not included in the Dow Jones index

When was Tevogen Bio Holdings's last earnings report?

Tevogen Bio Holdings's most recent earnings report was on Nov 19, 2024

When does Tevogen Bio Holdings report earnings?

The next expected earnings date for Tevogen Bio Holdings is Mar 14, 2025

Should I buy Tevogen Bio Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions